14 news items
NEW YORK COMMUNITY BANCORP, INC. AGREES TO SELL APPROXIMATELY $5 BILLION IN WAREHOUSE LOANS TO JPMORGAN CHASE BANK, N.A.
NYCB
14 May 24
or at all; and revenues following the transactions may be lower than expected. Additionally, there can be no assurance that the Community Benefits
NEW YORK COMMUNITY BANCORP, INC. REPORTS FIRST QUARTER 2024 RESULTS AND PROVIDES UPDATE ON ITS STRATEGIC PATH TO PROFITABILITY
NYCB
1 May 24
than expected. Additionally, there can be no assurance that the Community Benefits Agreement entered into with NCRC, which was contingent upon
NEW YORK COMMUNITY BANCORP, INC. ANNOUNCES NEW EMPLOYMENT INDUCEMENT AWARDS
NYCB
26 Apr 24
be lower than expected. Additionally, there can be no assurance that the Community Benefits Agreement entered into with NCRC, which was contingent upon
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, InMode, Innodata, and Fox Factory and Encourages Investors to Contact the Firm
FOXF
INMD
INOD
2 Apr 24
. InMode also assured investors that it had "obtained [FDA] clearance for the current treatments for which we offer our products" and that "no third-party
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, Amylyx, Xponential, and InMode and Encourages Investors to Contact the Firm
AMLX
INMD
NYCB
29 Mar 24
, Defendants repeatedly touted the demand for InMode's devices and told investors that those devices were never sold at a discount. InMode also assured
bf2tvpkt7j67mnd20w4y0m3cmep45jwgu8biwhxaosii9
AMLX
INMD
NYCB
25 Mar 24
were never sold at a discount. InMode also assured investors that it had "obtained [FDA] clearance for the current treatments for which we offer our
z6k3zlc7h dei7qni9ell92edflysu
AMLX
INMD
NYCB
21 Mar 24
touted the demand for InMode's devices and told investors that those devices were never sold at a discount. InMode also assured investors that it had
crxszwd4
AMLX
INMD
NYCB
17 Mar 24
assured investors that it had "obtained [FDA] clearance for the current treatments for which we offer our products" and that "no third-party claims have
bj56q9qzk0pf5wnd00b7evuigwl0lzd0ignqazwmq
NYCB
14 Mar 24
be no assurance that the Community Benefits Agreement entered into with NCRC, which was contingent upon the closing of the Company's merger with Flagstar
zuvnc ikfvli376jmz
INMD
LTRX
LUXH
13 Mar 24
devices were never sold at a discount. InMode also assured investors that it had "obtained [FDA] clearance for the current treatments for which we
hzno0f0zsum9alqjacxi82p6a0rf7
NYCB
11 Mar 24
the expected timeframes or at all; and revenues following the transactions may be lower than expected. Additionally, there can be no assurance
1rz6onf440k6a4u33hsihzk22ifu33g6i5qvw9djntordl82bgz1ypvb6pxq
INMD
LTRX
LUXH
9 Mar 24
never sold at a discount. InMode also assured investors that it had "obtained [FDA] clearance for the current treatments for which we offer our products
n6t8yhqe5f4 i8
NYCB
6 Mar 24
be no assurance that the Community Benefits Agreement entered into with NCRC, which was contingent upon the closing of the Company's merger
33ku m44ltndv5dmifrq2ygj3xyxr0ruoxmccnv
NYCB
6 Mar 24
the transactions may be lower than expected. Additionally, there can be no assurance that the Community Benefits Agreement entered into with NCRC
- Prev
- 1
- Next